Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome

OBJECTIVE It has been suggested that a hypofunctional hypothalamic-pituitary-adrenal (HPA) axis in chronic fatigue syndrome could result in an exaggerated release of pro-inflammatory cytokines during stress. As pro-inflammatory cytokines are involved in the induction of sickness behavior and thus constitute a potential physiological correlate of stress-induced symptom exacerbation in chronic fatigue syndrome, we set out to evaluate the LPS-induced production of pro-inflammatory cytokines during psychosocial stress in CFS and healthy controls. METHOD Twenty-one CFS patients and 20 healthy controls matched for age and gender underwent a standardized psychosocial stress test (Trier social stress test, TSST). Adrenocorticotropine hormone (ACTH), salivary cortisol and plasma cortisol levels were measured before and repeatedly following exposure to the stressor. Lipopolysaccharide-stimulated production of interleukin-6 and tumor necrosis factor-alpha were assessed at baseline as well as 10 and 60 min after the stress test. RESULTS CFS patients showed an inverse stress-induced response pattern of LPS-stimulated cytokines responses in comparison to healthy controls, i.e. stimulated cytokine production decreased shortly after stress in CFS patients, while it increased in controls. Fatigue scores and basal LPS-induced cytokine levels were significantly associated for TNF-alpha in controls and for both cytokines in CFS patients. Stress-induced changes in stimulated cytokine production were not associated with general fatigue scores in the control group, whereas in the CFS group, fatigue scores were significantly correlated with integrated levels of LPS-induced cytokines. However, partial correlations revealed that these results were due to the high correlations with basal LPS-induced cytokine levels. CONCLUSION CFS patients do not show an exaggerated secretion of LPS-induced cytokines. Although cortisol responses to stress were normal, pro-inflammatory cytokine levels in CFS patients were significantly attenuated. Possible intracellular mechanisms, such as for example an enhanced sensitivity to inhibitory effects of glucocorticoids, a diminished responsivity to catecholaminergic stimulation, and a disruption of intracellular activation are discussed. Basal levels of stimulated pro-inflammatory Il-6 levels are generally related to fatigue scores. However, in CFS patients this association is of greater magnitude and can also be observed for TNF-alpha.

[1]  U. Ehlert,et al.  Hypothalamic-Pituitary-Adrenal Axis Reactivity in Chronic Fatigue Syndrome and Health Under Psychological, Physiological, and Pharmacological Stimulation , 2002, Psychosomatic medicine.

[2]  D. Papanicolaou,et al.  Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. , 2002, Metabolism: clinical and experimental.

[3]  William R Lariviere,et al.  The role of corticotropin-releasing factor in pain and analgesia , 2000, Pain.

[4]  R. Bentall,et al.  The differential response of chronic fatigue, neurotic and muscular dystrophy patients to experimental psychological stress , 1994, Psychological Medicine.

[5]  J. Cidlowski,et al.  Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. , 1999, Endocrine reviews.

[6]  A. Cleare,et al.  The neuroendocrinology of chronic fatigue syndrome. , 2003, Endocrine reviews.

[7]  S. Wessely,et al.  Development of a fatigue scale. , 1993, Journal of psychosomatic research.

[8]  D. Papanicolaou,et al.  Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. , 1996, The American journal of physiology.

[9]  A Luger,et al.  Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. , 1987, The New England journal of medicine.

[10]  S. Sisto,et al.  Immunological Response in Chronic Fatigue Syndrome Following a Graded Exercise Test to Exhaustion , 2004, Journal of Clinical Immunology.

[11]  R. Patarca,et al.  Cytokines and Chronic Fatigue Syndrome , 2001, Annals of the New York Academy of Sciences.

[12]  R. Dantzer,et al.  Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? , 2003, Cancer.

[13]  G. Chrousos,et al.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. , 1997, Neuroimmunomodulation.

[14]  U. Ehlert,et al.  Enhanced glucocorticoid sensitivity in patients with chronic fatigue syndrome , 2003, Acta Neuropsychiatrica.

[15]  M. Demitrack,et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[16]  E. Bosmans,et al.  The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. , 1998, Cytokine.

[17]  D. Papanicolaou,et al.  Using an interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndrome , 2002, Psychological Medicine.

[18]  U. Ehlert,et al.  Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects. , 2003, Psychosomatics.

[19]  M. Demitrack,et al.  Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. , 1998, JAMA.

[20]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[21]  S. Gandevia,et al.  Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  A. Komaroff,et al.  Hormonal Influences on Stress-Induced Neutrophil Mobilization in Health and Chronic Fatigue Syndrome , 1998, Journal of Clinical Immunology.

[23]  Hans-Ulrich Wittchen,et al.  DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft , 1997 .

[24]  D. Papanicolaou,et al.  Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.

[25]  A Steptoe,et al.  Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. , 2001, Clinical science.

[26]  C. Kirschbaum,et al.  The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. , 1993, Neuropsychobiology.

[27]  M. Irwin,et al.  Interleukin-6 and Tumor Necrosis Factor-&agr; Production After Acute Psychological Stress, Exercise, and Infused Isoproterenol: Differential Effects and Pathways , 2000, Psychosomatic medicine.

[28]  T. Theorell,et al.  Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. , 1999, Psychosomatic medicine.

[29]  E. Lentjes,et al.  LPS-induced IL-10 production in whole blood cultures from chronic fatigue syndrome patients is increased but supersensitive to inhibition by dexamethasone , 2001, Journal of Neuroimmunology.

[30]  B. Natelson Chronic fatigue syndrome. , 2001, JAMA.

[31]  C. Kirschbaum,et al.  Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  Markus Schwaninger,et al.  A mechanism converting psychosocial stress into mononuclear cell activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Anisman,et al.  Cytokines, stress and depressive illness: brain‐immune interactions , 2003, Annals of medicine.

[34]  Gail Ironson,et al.  Physical Symptoms of Chronic Fatigue Syndrome Are Exacerbated By the Stress of Hurricane Andrew , 1995, Psychosomatic medicine.

[35]  H. Anisman,et al.  Sensitization to the Effects of Tumor Necrosis Factor-α: Neuroendocrine, Central Monoamine, and Behavioral Variations , 1999, The Journal of Neuroscience.

[36]  S. Kessler,et al.  Assessing health in musculoskeletal disorders – the appropriateness of a German version of the Sickness Impact Profile , 1997, Rheumatology International.

[37]  G. Leese,et al.  Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[38]  M. Sharpe,et al.  A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.

[39]  Ulrike Ehlert,et al.  Low-Dose Dexamethasone Suppression Test in Chronic Fatigue Syndrome and Health , 2002, Psychosomatic medicine.

[40]  F. Dhabhar,et al.  The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions , 1997, Brain Research Reviews.

[41]  D. Wakefield,et al.  Chronic Fatigue Syndrome: An Immunological Perspective , 1998, The Australian and New Zealand journal of psychiatry.

[42]  S. Wessely,et al.  Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial , 1999, The Lancet.

[43]  E. R. Kloet,et al.  Altered Glucocorticoid Regulation of the Immune Response in the Chronic Fatigue Syndrome , 2000, Annals of the New York Academy of Sciences.

[44]  E. Lentjes,et al.  Increased Sensitivity to Glucocorticoids in Peripheral Blood Mononuclear Cells of Chronic Fatigue Syndrome Patients, Without Evidence for Altered Density or Affinity of Glucocorticoid Receptors , 2001, Journal of Investigative Medicine.

[45]  E. D. de Kloet,et al.  CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. , 1998, The Journal of infectious diseases.

[46]  C. Schenck,et al.  Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. , 1994, Clinical and diagnostic laboratory immunology.

[47]  C. Kirschbaum,et al.  Glucocorticoid Sensitivity in Humans-Interindividual Differences and Acute Stress Effects , 2003, Stress.

[48]  R. Dantzer Cytokine-Induced Sickness Behavior: Where Do We Stand? , 2001, Brain, Behavior, and Immunity.

[49]  Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. , 2000 .

[50]  C. Kirschbaum,et al.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change , 2003, Psychoneuroendocrinology.